Journal article icon

Journal article

An algorithm for discontinuing mechanical ventilation in boys with x-linked myotubular myopathy after positive response to gene therapy: the ASPIRO experience

Abstract:
Availability of data and materials: Not applicable....The ASPIRO trial was sponsored by Astellas Gene Therapies (formerly Audentes Therapeutics) and was the impetus for development of the algorithm for weaning ventilator-dependent children with XLMTM off of ventilator support. Medical writing support from Laurie LaRusso, MS, ELS, of Chestnut Medical Communications was paid for by Astellas Gene Therapies
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1186/s12931-024-02966-0

Authors

More by this author
Role:
Author
ORCID:
0000-0002-8659-6313
More by this author
Role:
Author
ORCID:
0000-0002-3032-5434
More by this author
Role:
Author
ORCID:
0000-0002-8571-5552
More by this author
Role:
Author
ORCID:
0000-0002-9352-5388
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0009-0001-8219-6996


Publisher:
BioMed Central
Journal:
Respiratory Research More from this journal
Volume:
25
Issue:
1
Pages:
342-342
Publication date:
2024-09-16
DOI:
EISSN:
1465-993X
ISSN:
1465-9921


Language:
English
Keywords:
Pubs id:
2045600
Local pid:
pubs:2045600
Source identifiers:
W4402581951
Deposit date:
2026-01-22
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP